Norton Rose Fulbright harnesses the expertise of its team to advise innovative pharmaceutical, medical device, biotech companies, and industry investors, on matters spanning the full life sciences sector. The national practice handles regulatory and compliance, commercial and corporate, litigation and product liability, and intellectual property matters. In Toronto, Kristin Wall leads the team and is noted for her strength in complex litigation, administrative law, and intellectual property matters. Janet Grove KC in Vancouver regularly advises on domestic and cross-border M&A and financing transactions, alongside supply and licensing agreements. Vanessa Grant in Toronto also concentrates on M&As and licensing agreements, as well as corporate governance matters. Véronique Barry in Quebec City is well-versed in regulatory matters, including those involving technology, privacy, and protection of personal information.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Lawyer & team quality
Client satisfaction: Sector knowledge
Client satisfaction: NPS ®
Testimonials
Collated independently by Legal 500 research team.
- This practice is deeply embedded in the life sciences ecosystem. They understand and appreciate the subtle issues that affect the sector and offer appropriate services.
- Very deep understanding of the life science industry and experience across start-ups through to multi-nationals. As a result of that, NRF has the unique ability to advise and guide earlier stage companies on transactions and decisions that ultimately have an impact when the client companies have grown much larger. This breadth of life cycle experience is refreshing and brings significant advantages and learning to the client.
- We do business with this firm because the lawyers we will be dealing with are competent, serious and have a practical approach.
- The firm's case management and proactive approach are remarkable. The staff (lawyers, assistants) are highly professional, courteous, attentive, and take their cases to heart.
- This firm distinguishes itself through its combination of legal expertise, ingenuity, and tenacity. The team develops effective strategies tailored to its clients' needs, while remaining accessible, responsive, and results-oriented. Prospective clients will particularly appreciate the quality of advice, the pragmatic approach, and the firm's ability to find solutions where others see obstacles.
- The firm distinguishes itself through its expertise in public contracts, its knowledge of the Quebec health network, and its skills in the protection of personal information and access to data.
- Eric Malysa: Eric Malysa has been an excellent collaborator for our company. He is willing to work hard to deliver for our transactional needs and provides excellent advice.
- Vanessa Grant: Vanessa Grant brings the in-depth and extensive knowledge and competencies to bear when she is advising and executing on transactions.
- Véronique Barry: Véronique Barry has a deep understanding of this area of law. She is competent, well-versed in applicable laws, and brings a practical perspective to each case rather than a purely theoretical approach. She is always highly professional and readily available when an emergency arises. It's a pleasure to work with Véronique. She's my go-to person!
- Véronique Barry: It's a pleasure working with Véronique Barry. She is highly professional, dedicated, proactive, knowledgeable, and experienced. She listens attentively and always takes the time to fully understand each case. She consistently seeks the best solutions for her clients and is deeply committed to the development and realities of our organization. It's truly a pleasure to collaborate with her.
Key clients
- Bausch Health Canada
- Bausch + Lomb
- COSCIENS Biopharma
- Evonik
- ExCellThera
- InMed Pharmaceuticals
- Innovative Medicines Canada
- Janssen Pharmaceuticals
- OBIO
- Pfizer
- Siemens Healthineers
- TELUS Health
- Toronto Innovation Acceleration Partners
- University Health Network
- Zucara Therapeutics
Work highlights
Representing Bausch Health Canada in a proposed class proceeding in the Federal Court alleging price fixing and anti-competitive behaviour in the supply of generic drugs.
Representing Zucara Therapeutics, a biotech company specializing in treatment of Type-1 Diabetes, in advancing a clinical trial program, navigating regulatory requirements across Canada and the US and ensuring compliance with Health Canada and international clinical trial standards.
Representing Innovative Medicines Canada and BIOTECanada in a case heard in October 2025 by the Supreme Court of Canada, seeking to establish whether methods of medical treatment, specifically dosage regimens, are patentable in Canada.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Kristin Wall
Practice head
Kristin Wall
Other key lawyers
Vanessa Grant; Janet Grove KC; Tricia Kuhl; Randy Sutton; Orestes Pasparakis; Véronique Barry; Eric Malysa
